The Next Generation of COVID-19 Vaccines May Be Inhaled; Does Paxlovid Prevent Long COVID? Apply to the Morris Fishbein Fellowship in Medical Editing. Related Content: Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID The Morris Fishbein Fellowship in Medical Editing

Artificial intelligence holds the promise of revolutionizing disease diagnosis and prediction, but it also presents a pivotal challenge: ensuring equity. In this Q&A, Alondra Nelson, PhD, the Harold F. Linder Professor at the Institute for Advanced Study, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the equitable regulation of AI to benefit all populations. Related Content: How Do Policymakers Regulate AI and Accommodate Innovation in Research and...

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews John Ayers, PhD, MA, vice chief of innovation in the Division of Infectious Diseases & Global Public Health, deputy director of informatics in the Altman Clinical and Translational Research Institute, and affiliate scientist in the Qualcomm Institute, all at UC San Diego, to discuss how genAI programs like ChatGPT can increase communication pathways and improve patient outcomes. Related Content: ...

Why Physicians Don’t Deprescribe Medicines; What to Know About Wegovy’s Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug Related Content: As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management Deciding When It’s Better to Deprescribe Medicines Than to Continue Them

JAMA Associate Editor Gregory Marcus, MD, a cardiologist and professor of medicine at the University of California San Francisco, speaks with American Heart Association Scientific Sessions 2023 conference chair Amit Khera, MD, MSc, a professor in the department of internal medicine at UT Southwestern Medical Center and the director of preventive cardiology. Related Content: Highlights From AHA 2023—New Risk Calculator, Semaglutide and CVD, and More

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Nigam Shah, MBBS, PhD, professor of medicine at Stanford University and chief data scientist at Stanford Health Care, to discuss how large language models are reshaping medicine and the potential pitfalls of automation. Related Content: Clinical AI Tools Must Be Fed the Right Data, Stanford Health Care's Chief Data Scientist Says Creation and Adoption of Large Language Models in Medicine

New vaccines, artificial intelligence, antimicrobial resistance, and more—JAMA Deputy Editor Preeti Malani, MD, MSJ, speaks with IDWeek 2023 cochair Col Heather Yun, USAF, MC. The infectious disease physicians discuss clinical highlights from the conference. Related Content: Highlights From IDWeek 2023—New Vaccines, Artificial Intelligence, and Antimicrobial Resistance

JAMA Associate Editor John M. Inadomi, MD, discusses clinical highlights from United European Gastroenterology (UEG) Week with UEG president Helena Cortez-Pinto, MD, PhD. Related Content: Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More

AI has potential to meaningfully improve patient care. How will AI advances help clinicians focus on the best use of their time and talents? In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Suchi Saria, PhD, MSc, an associate professor in computer science at Johns Hopkins, to discuss how AI could streamline care. Related Content: Can Predictive AI Improve Early Detection of Sepsis and Other Conditions?

Who Should Get the New Alzheimer Disease Drug? Could Universal Donor Blood Be Made in the Lab? More Than 1 in 4 Nurses Say They Plan to Leave Health Care Related Content: Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug? Could Universal Donor Blood Be Made in the Laboratory? Overworked and Understaffed, More Than 1 in 4 US Nurses Say They Plan to Leave the Profession

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Bernard S. Chang, MD, MMSc, a neurologist and dean for medical education at Harvard Medical School, discuss how AI will change medical education, admissions, and teaching the future generation of physicians and clinicians. Related Content: AI Will—and Should—Change Medical School, Says Harvard’s Dean for Medical Education Transformation of Undergraduate Medical Education in 2023

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, talks with Andrew Bindman, MD, an internist and the executive vice president and chief medical officer for Kaiser Permanente, about AI implementation and the importance of building trust in a health care system. Related Content: Kaiser Permanente’s CMO: How AI Might Help Clinicians Address Patients’ Social Risk Factors

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Kedar S. Mate, MD, an internal medicine physician, President and Chief Executive Officer at the Institute for Healthcare Improvement, and faculty at Weill Cornell Medical College, to discuss AI’s role in health care quality and approaches to improving health equity. Related Content: New AI Tools Must Have Health Equity in Their DNA

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Kevin B. Johnson, MD, MS, the David L. Cohen and Penn Integrates Knowledge University Professor of Pediatrics, Informatics, Engineering, and Communication at the University of Pennsylvania, discuss how AI can reduce clinician burden and streamline health system functions. Related Content: Electronic Health Records Failed to Make Clinicians’ Lives Easier—Will AI Technology Succeed?

Should Consumers Buy a Blood Test to Evaluate Their Alzheimer Disease Risk; How Wildfire Smoke Harms Health Related Content: Consumers Can Now Buy a Blood Test to Evaluate Their Alzheimer Disease Risk, but Should They? Raging Wildfires Are Exposing More People to Smoky Air—Here’s What That Means for Health

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Ida Sim, MD, PhD, a primary care physician and UCSF’s Chief Research Informatics Officer, discuss generative AI, large language models, and the ways in which AI could affect humanity in medicine. Related Content: The Promise and Pitfalls of AI in the Complex World of Diagnosis, Treatment, and Disease Management

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Michael Howell, MD, MPH, a pulmonologist and chief clinical officer at Google, to discuss the evolution of AI and what we should expect next for AI and health care. Related Content: Google Health’s Chief Clinical Officer Talks About Incorporating AI in Health Care

Many health care professionals are already dealing with the effects of climate change. In this Q&A, the World Health Organization’s first-ever Special Envoy for Climate Change and Health, Vanessa Kerry, MD, MSc, joins JAMA Medical News Director Jennifer Abbasi to discuss how a changing climate and extreme weather events are impacting human health, what clinicians should expect in the years ahead, and how they can help protect patients—and the planet. Related Content: Critical Care...

What to Know About the First Pill Approved for Postpartum Depression; Will the Updated COVID Vaccines Protect Against the New Variant? CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant Related Content: A Fast-Acting Pill Received Approval for Postpartum Depression—Is It a Game Changer? What to Know About EG.5, the Latest SARS-CoV-2 “Variant of Interest” CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant

Treating Long COVID’s Mental Health Symptoms in Primary Care; This Fall’s COVID-19 Vaccine Will Target Omicron XBB Subvariants—Who Needs to Get It; Avian Influenza Update Related Content: HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID’s Mental Health Symptoms Vigilance Urged Against Bird Flu Amid Ongoing Outbreaks in Mammals This Fall’s COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen

Data on a new crop of hormone analogues for weight loss—including an oral version of semaglutide and the triple agent retatrutide—were recently presented at the American Diabetes Association’s annual Scientific Sessions. Robert Gabbay, MD, PhD, the ADA’s chief scientific and medical officer, speaks with JAMA’s Jennifer Abbasi about this and other clinical data presented at the meeting. Related Content: New Weight Loss Drugs Make Headlines at Diabetes Meeting

The 2021 US maternal mortality rate is more than 10 times the rate of other high-income countries, according to a March 2023 CDC report. In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, is joined by Monica McLemore, PhD, MPH, RN, University of Washington, Audra Meadows, MD, MPH, UC San Diego, and Joia Crear-Perry, MD, founder and president of the National Birth Equity Collaborative, to discuss these concerning numbers and why preventable death rates are worsening...

Sugar Substitutes Don’t Help Weight Control and May Increase Risk of Heart Disease and Diabetes, WHO Warns; Social Media and the Youth Mental Health Crisis Related Content: Sugar Substitutes Don’t Help Weight Control and May Increase Risk of Heart Disease and Diabetes, WHO Warns Surgeon General Sounds the Alarm on Social Media Use and Youth Mental Health Crisis

JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting’s Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute. Related Content: Highlights From the ASCO Annual Meeting—New Approaches to Cancers of the Blood, Brain, Lung, and More

JAMA Senior Editor Kristin L. Walter, MD, MS, speaks with Debra Boyer, MD, MHPE, about important research studies and keynote addresses presented at the American Thoracic Society International Conference in May 2023. Dr Boyer is a pediatric pulmonologist and chief medical education officer at Nationwide Children’s Hospital in Columbus, Ohio, and was cochair of this year’s conference. Related Content: COPD Mortality, Goals-of-Care Conversations in Serious Illness, and Advocating for...